Possibilities of a new assessment scale for prediction of chronic liver disease “CLivD”

Abstract

The number of patients with chronic liver disease (CLD) is steadily increasing. According to the 2023 update published by the European Association for the Study of the Liver, liver diseases account for two million deaths annually and account for 4% of all deaths (1 in every 25 deaths worldwide). This review emphasizes the need for early detection and control of these diseases course, as a factor that improves the patient's prognosis. It is proposed to use a new scale of the CLivD indicator (Chronic Liver Disease indicator), based on the assessment of risk factors widely available in physician practice, to predict the risk of developing progressive liver disease in the general population.